Today the MEP Heart Group meets in the European Parliament to debate the impact of industrially produced trans fatty acids on the health of citizens in the European Union.

EHN, together with leading research associations, scientific societies, universities, and patients groups, signed up to a statement supporting the current Directive 2010/63 on the protection of animals used in research.

In a 4-page interview for International Innovation, EHN Director Susanne Lá¸gstrup shares the significant progress made by the European Heart Network to promote effective evidence-based policies for cardiovascular health.

EHN has published today a statement on the new WHO Europe nutrient profile model, which has been developed in close cooperation with the Member States of WHO Europe.

Following a new study published today in Open Heart journal, EHN has published a statement on "Evidence on saturated fat and heart disease".

While negotiations continue on the Transatlantic Trade and Investment Partnership (TTIP), EHN has published a paper on “TTIP, international trade and cardiovascular health”.  Please find it here.

The EHN Screening Task Force has just updated its paper on cardiovascular risk assessment programmes.

The NGO signatories of this statement wholeheartedly welcome the announcement by President-elect Jean-Claude Juncker to leave the competence for pharmaceutical and medical devices with DG Sanco.

Together with 18 other NGOs, EHN wrote an open letter to Heads of State and Government expressing their concern about shifting pharma policy from DG Sanco to DG Industry.

In the run up to World Heart Day on 29 September 2014, the Global Cardiovascular Disease Taskforce has published a statement on "Sustainable Development Goals and the Future of Cardiovascular Health".  The Global Cardiovascular Disease Taskforce is a group of eminent experts who represent several leading heart-health organisations.